Experimental Physiology
The endocrine system produces molecules that are used to carry messages to various parts of the body
Some clinical results commonly attributed to Dihexa in marketing or popular press are actually fosgonimeton results
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
(While Ozempic, which lists the same possible side effects, is the most known GLP-1 drug, its not FDA approved for weight loss generally, which is a common misconception
Recognizing it as a biologically influenced response may help reduce frustration and self-blame